Matches 1 - 50 out of 435 1 2 3 4 5 6 7 8 9 >
Match Document Document Title
7615545 Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology  
This invention relates to a method of preventing pregnancy and treating PMS including PMDD. More particularly, the invention relates to a method, which involves administering one of several...
7608616 Methods for reducing the risk of an adverse drug interaction in a patient suffering from insomnia  
Disclosed herein is a method for treating a patient with Quazepam that reduces the risk of an adverse interaction between the Quazepam and drug that is a substrate of the cytochrome P450 enzyme...
7601876 Compounds, compositions and methods for the treatment of amyloid diseases such as systemic AA amyloidosis  
Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs and pharmaceutically acceptable esters, their synthesis, pharmaceutical compositions containing them, and their use in the...
7589127 Aminoalkylphenols, methods of using and making the same  
The present invention relates to Mannich base antimalarial aminoalkylphenol compounds and their use against protozoa of the genus Plasmodium , particularly emerging strains of drug-resistant...
7585897 Modified release formulations of a bupropion salt  
The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of...
7576073 Combined therapy for the treatment of parkinson's disease  
The present invention concerns a method and a pharmaceutical composition for treating the symptoms associated to Parkinson's disease. The method and the pharmaceutical composition use a combination...
7563930 Crystal forms of Cinacalcet HCI and processes for their preparation  
Provided are crystalline forms of Cinacalet HCl and processes for their preparation.
7553834 Method for the targeted treatment of depression  
A method for determining the appropriate medication for a patient suffering from depression. A patient will take a questionnaire wherein the patient answers a number of questions with scaled...
7550466 Alpha and/or β-adrenergic antagonists and agonists to treat pain  
The present disclosure provides for improved methods for treating pain, including pain associated with chronic inflammatory diseases, neuropathic pain and cancer by using α-adrenergic antagonists...
7541384 Mesalamine suppository  
The present invention relates to a mesalamine rectal suppository designed to provide improved comfort of use. One embodiment of the invention is a mesalamine rectal suppository containing...
7528175 Method of treating airway diseases with beta-adrenergic inverse agonists  
The use of β-adrenergic inverse agonists provides a new and highly efficient way of treating a number of pulmonary airway diseases, including asthma, emphysema, and chronic obstructive pulmonary...
7514470 Aniline derivatives as selective androgen receptor modulators  
This invention relates to non-steroidal compounds that are modulators of androgen, glucocorticoid, mineralocorticoid, and progesterone receptors, and also to the methods for the making and use of...
7511073 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof  
One aspect of the present invention relates to amines. A second aspect of the present invention relates to the use of the amines as inhibitors of a mammalian anandamide transporter. The compounds...
7504422 Polyamine compounds  
This invention relates to methods for treating retinopathy and repairing tissue damage. The methods include administering to a subject in need thereof an effective amount of one or more compounds...
7488759 Malic acid addition salts of terbinafine  
The invention concerns salts of the compound of formula I with malic acid, their preparation, corresponding pharmaceutical compositions and their use as antimycotics.
7485320 Liposome for incorporating large amounts of hydrophobic substances  
A liposome formulation for stably incorporating high content of hydrophobic substance is disclosed. The liposome includes two phospholipids with different phase transition temperatures such as...
7482491 Amino alcohol derivative, addition salt thereof, and immunosuppressant  
An amino alcohol derivative represented by the following general formula (1) (for example, (±)-2-amino-5-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-2- methylpentane-1-ol) exhibits strong...
7462618 Treatment of inflammatory autoimmune diseases with alpha-adrenergic antagonists and beta-adrenergic agonists  
The present invention discloses a novel compound and method for the treatment of inflammatory autoimmune diseases, for example, rheumatoid arthritis, using α-adrenergic antagonists and...
7456317 Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity  
Chemical syntheses and medical uses of novel inhibitors of the uptake of monoamine neurotransmitters and pharmaceutically acceptable salts and prodrugs thereof, for the treatment and/or management...
7456222 Anti tubercular drug: compositions and methods  
Methods and compositions for treating disease caused by infectious agents, particularly tuberculosis. In particular, methods and compositions comprising substituted ethylene diamines for the...
7439241 Compounds, formulations, and methods for treating or preventing rosacea  
In methods, compounds, and topical formulations for treatment of rosacea incorporating compounds represented by the formulas below: wherein each of R 1 , R 2 , and R 3 is independently...
7431916 Administration of medicinal dry powders  
A method of administering a metered dry powder combined dose of finely divided dry medication powders is disclosed, wherein said method comprises providing a relative motion between a nozzle of a...
7427639 β2-adrenergic receptor agonists  
Disclosed are multibinding compounds which are β2 adrenergic receptor agonists and are useful in the treatment and prevention of respiratory diseases such as asthma, bronchitis. They are also...
7427414 Modified release oral dosage form using co-polymer of polyvinyl acetate  
Once a day modified release oral dosage form comprising of granules or pellets which are either compressed into tablet or filled inside the capsule, wherein the pellet has a core of active...
7402698 Secondary amino-and cycloamino-cycloalkanol derivatives and methods of their use  
The present invention is directed to secondary amino- and cycloamino-cycloalkanol derivatives, compositions containing these derivatives, and methods of their use for the prevention and treatment...
7399776 Polyamine compounds for treating chemokine receptor mediated diseases  
This invention relates to a method for treating inflammatory diseases or immune diseases, developmental or degenerative diseases, or tissue injuries. The method includes administering to a subject...
7384983 Inhibitor of monoamine uptake  
The present invention provides compounds and methods for the inhibition of monoamine uptake in mammals.
7375111 Compositions for affecting weight loss  
Disclosed are compositions for affecting weight loss comprising a first compound and a second compound, where the first compound is an opioid antagonist and the second compound causes increased...
7368440 Methods for the administration of amifostine and related compounds  
The present invention provides methods of administering amifostine, WR-1065, or a combination thereof, to patients receiving radiation therapy or chemotherapy in a manner that significantly reduces...
7332525 Method of treatment of prostate cancer and composition for treatment thereof  
A method and composition for the treatment of prostate cancer comprises an effective amount of a nonsteroidal antiandrogen and an effective amount of a selective estrogen receptor modulator. The...
7294649 Methamphetamine derivatives and conjugates for immunoassay  
Compounds of methamphetamine derivatives having a meta-substituted alkyl linker on the benzene ring and a protective group on the nitrogen of the methamphetamine hapten. Such compounds have the...
7288571 Thyroid receptor ligands and method II  
New thyroid receptor ligands are provided which have general formula (I) in which: n is an integer from 0 to 4; R 1 is halogen, trifluoromethyl, or alkyl of 1 to 6 carbons or cycloalkyl of 3 to 7...
7276518 Substituted cyclohexane-1,4-diamine compounds  
Substituted cyclohexane-1,4-diamine compounds, methods for production thereof, pharmaceutical compositions comprising these compounds and methods of treatment using these compounds.
7267949 Composition comprising methylphenidate and another drug  
A process of treating a subject that is undergoing methylphenidate therapy and concomitant therapy with another drug undergoes or interferes with P 450 metabolism, wherein the methylphenidate is...
7261889 Local anesthetic methods and kits  
Methods of reversing local anesthesia are disclosed. The methods comprise administering a local anesthetic and alpha adrenergic receptor agonist to induce local anesthesia followed by reversing...
7230018 Substituted propane-1,3-diamine derivatives and the pharmaceutical use thereof  
Substituted propane-1,3-diamine derivatives, methods for producing such derivatives, and medicaments and pharmaceutical compositions containing such derivatives useful for the treatment or...
7220782 Methods to reduce the sensitivity of endothelially-compromised vascular smooth muscle  
The present invention discloses materials and methods useful to treat sensitivity of endothelially-compromised vascular smooth muscle. In one embodiment, CLC3 blockers, particularly compounds of...
7176243 CaR receptor as a mediator of migratory cell chemotaxis and/or chemokinesis  
This invention relates to methods and compositions for modulating movement of eukaryotic cells with migratory capacity. More specifically, the invention relates to methods and compositions for...
7169750 Methods to mobilize progenitor/stem cells  
Methods to elevate progenitor and stem cell counts in animal subjects using compounds which bind to the chemokine receptor CXCR4 are disclosed. Preferred embodiments of such compounds are of the...
7160857 Methods for increasing schwann cell survival  
Methods for increasing Schwann cell survival are disclosed. The methods of the invention are useful for the treatment of conditions such as peripheral neuropathies, including diabetic neuropathies.
7144920 Polyamine analogs that activate antizyme frameshifting  
Novel polyamines, their synthesis and use in pharmacological, cosmetic or agricultural applications are provided. The polyamines induce antizyme production which in turn down regulates both the...
7138405 Pharmaceutical combinations  
Pharmaceutical combinations suitable for treating the lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH) in men are described herein. The combinations contain an...
7135497 Treating neural conditions resulting from spinal cord contusions and other causes  
β 2 -agonists, such as clenbuterol and salbutamol can enhance the recovery of locomotive function and/or neuromuscular strength following spinal cord injuries or as a result of degenerative neural...
7122308 Detection of antidepressant induced mania  
Methods and kits for assessing the susceptibility of a patient to antidepressant-induced mania are described. The method involves testing a sample from a patient for the presence of the s variant...
7109198 Method for treating obesity  
The present invention relates, in general, to obesity, and, in particular, to a method of treating obesity and minimizing metabolic risk factors associated therewith using, for example, zonisamide...
7105575 Methods for the treatment of neuro- disorders using aminothiol compounds  
The present invention relates to new uses of S-2-(3-aminopropylamino)ethyl dihydrogen phosphorothioate, (amifostine) and other aminothiol compounds to treat and reverse toxicities caused by...
7101572 Taste masked aqueous liquid pharmaceutical composition  
A substantially taste masked liquid pharmaceutical composition containing a pharmaceutically effective amount of an unpleasant tasting drug dissolved or dispersed in an aqueous excipient base, said...
7094431 Method of healing skin wounds in mammals and a composition therefor  
This invention pertains to therapeutic antibacterial/antifungal-wound healing compositions comprising a therapeutically effective amount of antibacterial agents and/or antifungal agents and/or...
RE39221 Composition comprising a tramadol material and acetaminophen and its use  
This invention relates to a composition comprising a tramadol material and acetaminophen, and its use. As used herein tramadol refers to various forms of tramadol. The compositions are...
7071194 Method for improving respiratory function and inhibiting muscular degeneration  
The present invention provides a method for improving respiratory function and inhibiting muscular degeneration (e.g., dystrophy and atrophy). Alternative embodiments of the invention provide a...
Matches 1 - 50 out of 435 1 2 3 4 5 6 7 8 9 >